Navigation Links
Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination
Date:6/29/2009

DENVER, June 29 /PRNewswire-FirstCall/ -- Air Methods Corporation (Nasdaq: AIRM), the largest air medical transportation company in the world, announced today it has filed a petition with the National Transportation Safety Board (NTSB) requesting the Board reconsider/modify its probable cause determination related to the June 29, 2008 mid-air collision accident in Flagstaff, Arizona. The NTSB Probable Cause Report states that "both pilots failed to see and avoid the other helicopter on approach to the helipad".

Specifically, Air Methods' petition seeks the following of the NTSB [Board]:

  1. Reconsideration and deletion of the Board's finding that a contributing cause in the accident was "the failure of Air Methods' pilot to follow arrival and noise abatement guidelines;"
  2. The addition, as a contributing cause, the presence of prescription pain-killing medication in the Classic pilot's blood that could influence decisions or performance; and
  3. The addition, as a contributing cause, of the failure of the Classic communications center to communicate pertinent information to the Classic aircraft regarding the fact that Air Methods' aircraft was inbound to Flagstaff Medical Center (FMC) with the same estimated time of arrival as the Classic aircraft.

Aaron Todd, CEO, stated, "Air Methods has filed a petition with the NTSB requesting that the Board reconsider/modify the probable cause/contributing cause determination of this accident. We are deeply troubled by what we consider to be critical inaccuracies in the NTSB current Probable Cause Report and the inconsistencies between the findings in this case versus previous cases."

Air Methods Corporation (www.airmethods.com) is a leader in emergency air medical transportation and medical services. The Hospital-Based Services Division is the largest provider of air medical transport services for hospitals. The Community-Based Services Division is the largest community-based provider of air medical services. The Products Division specializes in the design and manufacture of aeromedical and aerospace technology. The Company's fleet of owned, leased or maintained aircraft features over 300 helicopters and fixed wing aircraft.

Forward Looking Statements: This news release includes certain forward-looking statements, which are subject to various risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including but not limited to the size, structure and growth of the Company's air medical services and products markets; the collection rates for patient transports; the continuation and/or renewal of air medical service contracts; the acquisition of profitable Products Division contracts and other flight service operations; the successful expansion of the community-based operations; and other matters set forth in the Company's public filings.

CONTACTS: Aaron D. Todd, Chief Executive Officer, (303) 792-7413. Please contact Christine Clarke at (303) 792-7579 to be included on the Company's fax and/or mailing list.


'/>"/>
SOURCE Air Methods Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Major New Report Establishes Effective Methods of Enhancing and Preserving Brain Power as We Age
2. Air Methods Expands Community-Based Operations Into Eastern Oklahoma
3. Prominent Farmington Hills Plastic Surgeon Suggests Methods to Repair Skin Damaged by Sun Exposure
4. New Methods Could Speed Production of Flu Vaccines
5. Webcast Alert: Air Methods to Announce First Quarter 2009 Financial Results
6. Long Term Care Alerting Methods Revealed by Industry Leaders
7. Air Methods Preliminary 1st Qtr. Results Exceed Expectations
8. Air Methods Announces Year 2008 Financial Results and Provides First Quarter 2009 Update
9. Air Methods to Report Fourth Quarter and Fiscal Year 2008 Financial Results on Tuesday, March 10, 2009
10. Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention
11. Early Detection Methods for Pancreatic Cancer Urgently Needed: A Statement From the Pancreatic Cancer Action Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! God’s ... to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A Story ... couple from Long Island, New York. , Published by Christian Faith Publishing, Dale Anthony ...
(Date:8/18/2017)... ... ... ... For Immediate Release                Contact: Julian Teixeira, August ... Seek Sex and Relationship Advice from their Fathers , ...
(Date:8/18/2017)... York, NY (PRWEB) , ... August 18, 2017 ... ... launch of this summer’s edition of “Vision & Hearing,” advocating for active, healthy ... campaign focuses on resources available for individuals with hearing impairments and shares the ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, a Missouri-based ... drive to generate community support for efforts to educate the local population on cancer ... all types of cancer. , Each day in America, roughly 4,600 new cases ...
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017   Mostyn Law and Gulf ... Houston, Texas . The Mostyn Law family ... 2 years. That is why Mostyn Law is partnering ... to show its appreciation. Blood supplies are running ... 5% short of hospital needs in August. That is why the ...
(Date:8/15/2017)...  AOTI Inc. announced today that its fully owned ... a New York City Office in Yonkers, New York ... Wound Oxygen (TWO 2 ) homecare therapy. This new East Coast ... Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment ... Advanced Oxygen Therapy ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: